Programming - Hypertension Scientific Sessions
Marriott Baltimore Waterfront | Baltimore, Maryland
Hypertension 2025 Final Schedule
Time | Activity |
---|---|
6:00 pm to 7:00 pm | Hypertension Journal Meet the Editors Networking Event Dover A-C (open to all) |
7:00 pm to 9:00 pm | Opening Reception and Networking Session Dover A-C (open to all) |
Time | Activity |
---|---|
7:30 am to 8:00 am |
Welcome and Opening Remarks 7:30 7:45 Steven D. Crowley, MD |
8:00 am to 10:00 am |
Session 1 8:00 to 8:35 8:35 to 9:35 9:35 to 10:00 |
10:00 am to 10:30 am | Break |
10:30 am to 12:00 pm |
Session 2 - Concurrent Sessions A, B and C Concurrent 2A: 10:30 a.m. 001 002 003 004 Concurrent B: 10:30 AM
Invited Lecture: 005 006 007 008 Concurrent C: 10:30 AM Invited Lecture 009 010 011 012 |
12:00 pm to 1:00 pm |
Session 3 |
1:00 pm to 1:30 pm | Sponsored Learning Studio Astra Zeneca Grand Ballroom 6 |
1:30 pm to 3:00 pm |
Session 4 1:30 – 2:00 PM Harriet Dustan Lecture: 2:00 - 3:00PM RF01 RF02 RF03 RF04 RF05 RF06 RF07 RF08 RF09 RF10 |
3:00 pm to 3:30 pm | Break |
3:30 pm to 5:30 pm |
Session 5 Concurrent C Concurrent 5A: 013 014 015 016 017 018 019 020 Concurrent 5B: 021 022 023 024 025 026 027 028 Concurrent 5C 3:30 to 4:30 p.m. 3:30 3:40 3:50 4:00 4:10-4:30 4:30 to 5:30 p.m. 4:30 4:42 4:54 5:06 5:18 to 5:30 |
5:30 pm to 7:00 pm | Poster Session 1 and Reception Harborside Ballroom Includes the TAC Poster Competition |
Time | Activity |
---|---|
7:00 am to 8:00 am | Session 6 Inside the AHA's Research Enterprise: Grant Funding and Other Opportunities Glenn Dillon, PhD |
7:15 am to 7:45 am | Sponsored Learning Studio Grand Ballroom 6 Recor Medical |
8:00 am to 9:00 am |
Session 7 8:00 8:30 |
9:00 am to 10:30 am | Poster Session 2 With Breakfast Reception Harborside Ballroom |
10:30 am to 12:00 pm |
Session 8 Concurrent 8A - TAC Oral Abstract Award Competition 029 030 031 032 033 034 Concurrent 8B - Let's Get Specific: Sex Differences, Dimorphisms, and Disparities in Hypertension 035 036 037 038 039 040 Concurrent Session C - Unpacking the 2025 AHA/ACC High Blood Pressure Guideline: What’s New and What It Means for Your Practice |
12:00 pm to 1:30 pm | Session 9 CHAMP Lunch Event (You must preregister prior to the conference) Dover A-C |
12:30 pm to 1:00 pm | Sponsored Learning Studio Medtronic Grand Ballroom 6 |
1:30 pm to 3:00 pm |
Session 10 Concurrent 10A: 1:30 PM 041 042 043 044 Concurrent 10B: 1:30 PM 045 046 047 048 Concurrent 10C: Presenters: 1:40 PM 1:50 PM 2:00 PM 2:10 PM 2:20 PM 2:30 PM |
3:00 pm to 3:30 pm | Break |
3:30 pm to 5:30 pm |
Session 11 3:30 – 4:00 3:30 PM 3:40 PM 3:50 PM 4:00 – 4:45 049 4:15 PM |
5:30 pm to 6:30 pm |
Session 12 From Endocrine, Paracrine to Intracrine Angiotensin II: What Else Is Left for Angiotensin II-Dependent Hypertension Research? |
7:00 pm to 10:00 pm |
Trainee Advocacy Mixer Event |
Time | Activity |
---|---|
7:00 am to 7:30 am | Sponsored Learning Studio Idorsia |
7:30 am to 9:00 am |
Session 13 Genetic Risk of Chronic Kidney Disease in Special Populations 8-8:30 050 051 052 053 |
9:00 am to 10:00 am |
Session 14 Concurrent 14A 054 055 056 057 Concurrent 14B 058 059 060 061 Concurrent 14C 9:00 9:30 |
10:00 am to 10:30 am | Break |
10:30 am to 12:00 pm |
Session 15 Concurrent 15A - Renin Angiotensin System 10:30 AM 062 063 064 065 Concurrent 15B 10:30 AM 066 067 068 069 Concurrent 15C 10:30 AM 070 071 072 073 |
12:30 pm to 1:00 pm | Sponsored Learning Studio Corcept Therapeutics |
1:00 pm to 1:30 pm | Sponsored Learning Studio Mineralys Therapeutics |
12:00 pm to 1:30 pm | Or Lunch on Your Own |
1:30 pm to 3:00 pm |
Session 16
Concurrent Sessions A and B
Concurrent 16A 1:30 PM 074 075 076 077 Concurrent 16B 1:30 PM 078 079 080 081 Concurrent Session C: Hypertension Across the Lifespan 1:30 1:50 2:10 2:30 2:50 - 3:00 |
3:00 pm to 3:30 pm | Break |
3:30 pm to 5:30 pm |
Session 17 3:30 PM 4:00 PM Concurrent Sessions A and B 3:30 – 5:30 Concurrent17 A 082 083 084 085 Concurrent 17B 086 087 088 089 3:30 – 5:30 3:30 – 4:30 PM 3:30 3:45 4:00 4:15 4:30 – 5:30 PM 4:30 4:45 5:00 5:30 |
5:45 pm to 6:15 pm |
Session 18 5:45 PM 6:05 PM |
7:00 pm to 10:00 pm |
Council Awards Banquet Includes the presentation of the following Awards: Fernando Elijovich Early Career Clinician Scientist Award Irvine Page -Alva Bradley Lifetime Achievement Award Excellence Award for Hypertension Research |
Time | Activity |
---|---|
8:00 am to 9:30 am |
Session 19 Concurrent 19A 8:00 AM 090 091 092 093 Concurrent 19B 8:00 AM 094 095 096 097 Concurrent 19C 19C1 Presenters: 8:00 AM
8:10 AM
8:20 AM
8:30 AM
19C2 8:45 8:50 9:00 9:10- 9:30 |
9:30 am to 10:00 am | Break |
10:00 am to 11:30 am |
Session 20 Concurrent 20A 10:00 AM 098 099 100 101 Concurrent 20B 102 103 104 105 Concurrent 20C 10:00 AM 106 107 108 109 |
11:30 am to 12:00 pm |
Session 21 Fate of Renal Cells in Health and Disease |
About This Meeting
Hypertension 2025 Scientific Sessions is considered the premier scientific meeting on the subject in the world. A collaborative effort between the Council on Hypertension and the Council on the Kidney in Cardiovascular Disease, the science submitted to this conference continues to bring us the most up to date developments on our understanding of: the causes of hypertension; its relationship to stroke, cardiac disease and kidney dysfunction; and the most effective means for detecting, evaluating and treating high blood pressure across diverse populations.
This year's programming also includes:
- Recent Advances sessions and lectures on cutting-edge science, followed by oral abstract presentations
- Clinical Science/Clinical Practice track
- Primary Care track
- Oral abstract sessions highlighting Early Career oral abstract presentations
- Networking sessions
- Trainee Advocacy Committee (TAC) Poster session and competition
- Award Lecture sessions
Learning Objectives
- Discuss recent advances and emerging experimental models in hypertension and kidney disease.
- Summarize findings from recent clinical trials and the impact on future treatment and/or management of hypertensive and kidney-related disorders.
- Describe new therapeutic options and technologies for patients with hypertension and kidney disease.
- Describe the most up-to-date clinical guideline recommendations for the prevention, diagnosis, and management of hypertension and kidney disease.